Literature DB >> 29444413

Involvement of Alveolar Epithelial Cell Necroptosis in Idiopathic Pulmonary Fibrosis Pathogenesis.

Ji-Min Lee1, Masahiro Yoshida2, Mi-So Kim1, June-Hyuk Lee1, Ae-Rin Baek1, An Soo Jang1, Do Jin Kim1, Shunsuke Minagawa2, Su Sie Chin3, Choon-Sik Park1, Kazuyoshi Kuwano2, Sung Woo Park1, Jun Araya2.   

Abstract

Alveolar epithelial cell (AEC) injury leading to cell death is involved in the process of fibrosis development during idiopathic pulmonary fibrosis (IPF). Among regulated/programmed cell death, the excessive apoptosis of AECs has been widely implicated in IPF pathogenesis. Necroptosis is a type of regulated/programmed necrosis. A multiprotein complex composed of receptor-interacting protein kinase (RIPK)-1 and -3 plays a key regulatory role in initiating necroptosis. Although necroptosis participates in disease pathogeneses through the release of damage-associated molecular patterns, its association with IPF progression remains elusive. In this study, we attempted to illuminate the involvement of RIPK3-regulated necroptosis in IPF pathogenesis. IPF lung tissues were used to detect necroptosis, and the role of RIPK3 was determined using cell culturing models of AECs. Lung fibrosis models of bleomycin (BLM) treatment were also used. RIPK3 expression levels were increased in IPF lungs, and both apoptosis and necroptosis were detected mainly in AECs. Necrostatin-1 and RIPK3 knockout experiments in AECs revealed the participation of necroptosis in BLM and hydrogen peroxide-induced cell death. BLM treatment induced RIPK3 expression in AECs and increased high-mobility group box 1 and IL-1β levels in mouse lungs. The efficient attenuation of BLM-induced lung inflammation and fibrosis was determined in RIPK3 knockout mice and by necrostatin-1 with a concomitant reduction in high-mobility group box 1 and IL-1β. RIPK3-regulated necroptosis in AECs is involved in the mechanism of lung fibrosis development through the release of damage-associated molecular patterns as part of the pathogenic sequence of IPF.

Entities:  

Keywords:  apoptosis; idiopathic pulmonary fibrosis; necroptosis; necrostatin; receptor-interacting protein kinase-3

Mesh:

Substances:

Year:  2018        PMID: 29444413     DOI: 10.1165/rcmb.2017-0034OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  28 in total

1.  Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis.

Authors:  Xiaoyun Li; Sharon E Kim; Ting-Yun Chen; Juan Wang; Xia Yang; Tracy Tabib; Jiangning Tan; Brandon Guo; Sonia Fung; Jing Zhao; John Sembrat; Mauricio Rojas; Sruti Shiva; Robert Lafyatis; Claudette St Croix; Jonathan K Alder; Y Peter Di; Daniel J Kass; Yingze Zhang
Journal:  FASEB J       Date:  2020-06-28       Impact factor: 5.191

Review 2.  Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.

Authors:  Jeremy Katzen; Michael F Beers
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 3.  Necroptosis: a crucial pathogenic mediator of human disease.

Authors:  Mary E Choi; David R Price; Stefan W Ryter; Augustine M K Choi
Journal:  JCI Insight       Date:  2019-08-08

4.  Isoflavone-mediated radioprotection involves regulation of early endothelial cell death and inflammatory signaling in Radiation-Induced lung injury.

Authors:  Matthew D Fountain; Laura A McLellan; Natalie L Smith; Brian F Loughery; Joseph T Rakowski; Harley Y Tse; Gilda G Hillman
Journal:  Int J Radiat Biol       Date:  2019-11-04       Impact factor: 2.694

5.  LRRK2 plays essential roles in maintaining lung homeostasis and preventing the development of pulmonary fibrosis.

Authors:  Yujie Tian; Jiaoyan Lv; Ziyan Su; Tao Wu; Xiaoguang Li; Xiaoyu Hu; Jianhong Zhang; Li Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-31       Impact factor: 11.205

6.  Inhibition of HMGB1/RAGE Signaling Reduces the Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Mice.

Authors:  Ioannis Gkouveris; Danny Hadaya; Naseim Elzakra; Akrivoula Soundia; Olga Bezouglaia; Sarah M Dry; Flavia Pirih; Tara Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2022-07-11       Impact factor: 6.390

Review 7.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

8.  Human bronchial epithelial cell-derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF-β-WNT crosstalk.

Authors:  Tsukasa Kadota; Yu Fujita; Jun Araya; Naoaki Watanabe; Shota Fujimoto; Hironori Kawamoto; Shunsuke Minagawa; Hiromichi Hara; Takashi Ohtsuka; Yusuke Yamamoto; Kazuyoshi Kuwano; Takahiro Ochiya
Journal:  J Extracell Vesicles       Date:  2021-08-02

9.  Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis.

Authors:  Cory Wilson; Tinne Cj Mertens; Pooja Shivshankar; Weizen Bi; Scott D Collum; Nancy Wareing; Junsuk Ko; Tingting Weng; Ram P Naikawadi; Paul J Wolters; Pascal Maire; Soma Sk Jyothula; Rajarajan A Thandavarayan; Dewei Ren; Nathan D Elrod; Eric J Wagner; Howard J Huang; Burton F Dickey; Heide L Ford; Harry Karmouty-Quintana
Journal:  JCI Insight       Date:  2022-05-23

Review 10.  PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses.

Authors:  Kazuya Tsubouchi; Jun Araya; Kazuyoshi Kuwano
Journal:  Inflamm Regen       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.